Lantheus Holdings Inc. (LNTH) Financial Statements (2025 and earlier)

Company Profile

Business Address 331 TREBLE COVE ROAD
NORTH BILLERICA, MA 01862
State of Incorp. DE
Fiscal Year End December 31
Industry (SIC) 2835 - In Vitro and In Vivo Diagnostic Substances (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)

9/30/2024
MRQ
12/31/2023
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments713,656415,65298,50879,61292,919113,401
Cash and cash equivalents713,656415,65298,50879,61292,919113,401
Receivables284,292213,39789,33654,00243,52943,753
Inventory, net of allowances, customer advances and progress billings64,02935,47535,12935,74429,18033,019
Inventory64,02935,47535,12935,74429,18033,019
Disposal group, including discontinued operation7,159  5,242  
Other current assets16,68313,09212,8189,6257,2835,242
Total current assets:1,085,819677,616235,791184,225172,911195,415
Noncurrent Assets
Finance lease, right-of-use asset, after accumulated amortization    348
Operating lease, right-of-use asset    935
Property, plant and equipment     107,888
Intangible assets, net (including goodwill)213,174376,474409,699434,64423,05024,847
Goodwill61,18961,18961,18958,63215,71415,714
Intangible assets, net (excluding goodwill)151,985315,285348,510376,0127,3369,133
Regulated entity, other noncurrent assets    774 
Deferred income tax assets150,198110,64762,76470,14771,834
Other noncurrent assets55,26134,35538,75860,63421,62730,232
Other undisclosed noncurrent assets146,697122,166116,772120,171114,44081,449
Total noncurrent assets:565,330643,642627,993685,596233,008244,416
TOTAL ASSETS:1,651,1491,321,258863,784869,821405,919439,831
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities102,92885,18151,72143,00742,72337,630
Employee-related liabilities22,73017,66915,10015,962
Accounts payable41,18920,56320,78716,28418,60817,955
Accrued liabilities61,73964,6188,2049,0549,0153,713
Debt82370812,03420,95010,4792,750
Disposal group, including discontinued operation    1,793  
Business combination, contingent consideration, liability  99,700    
Other undisclosed current liabilities83,59962,11226,74214,75412,90912,375
Total current liabilities:187,350247,70190,49780,50466,11152,755
Noncurrent Liabilities
Long-term debt and lease obligation, including:561,670557,712163,121197,699183,927263,709
Long-term debt, excluding current maturities  557,712163,121197,699183,927263,709
Finance lease, liability625    
Other undisclosed long-term debt and lease obligation 561,045     
Liabilities, other than long-term debt86,23768,698145,72777,41341,28052,365
Asset retirement obligations22,91622,54320,83314,02012,88311,572
Other liabilities63,32146,155124,89463,39328,39740,793
Total noncurrent liabilities:647,907626,410308,848275,112225,207316,074
Total liabilities:835,257874,111399,345355,616291,318368,829
Equity
Equity, attributable to parent815,892447,147464,439514,205114,60171,002
Common stock699689677669393385
Treasury stock, value(75,000)(75,000)    
Additional paid in capital757,727715,875685,472665,530251,641239,865
Accumulated other comprehensive loss(1,037)(1,259)(485)(2,048)(960)(1,108)
Retained earnings (accumulated deficit)133,503(193,158)(221,225)(149,946)(136,473)(168,140)
Total equity:815,892447,147464,439514,205114,60171,002
TOTAL LIABILITIES AND EQUITY:1,651,1491,321,258863,784869,821405,919439,831

Income Statement (P&L) ($ in thousands)

9/30/2024
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
Revenues1,296,429935,061425,208339,410347,337343,374
Cost of revenue(586,886)(353,358)(237,513)(200,649)(172,526)(168,489)
Cost of goods and services sold(586,886)(353,358)(237,513)(200,649)(172,526)(2,875)
Gross profit:709,543581,703187,695138,761174,811174,885
Operating expenses(344,901)(545,508)(263,783)(142,959)(123,150)(110,397)
Other undisclosed operating income  15,263   
Operating income (loss):364,64236,195(60,825)(4,198)51,66164,488
Nonoperating income (expense)
(Other Nonoperating Income (Expense))
66,320(1,703)(7,350)2,198(6,221)2,465
Interest and debt expense(20,019)(7,773)(6,863)(9,479)(16,813)(17,405)
Income (loss) from continuing operations before equity method investments, income taxes:410,94326,719(75,038)(11,479)28,62749,548
Other undisclosed income from continuing operations before income taxes      
Income (loss) from continuing operations before income taxes:410,94326,719(75,038)(11,479)28,62749,548
Income tax expense (benefit)(84,282)1,3483,759(1,994)3,040(9,030)
Income (loss) from continuing operations:326,66128,067(71,279)(13,473)31,66740,518
Income (loss) before gain (loss) on sale of properties:(71,279)(13,473)31,66740,518
Net income (loss) available to common stockholders, diluted:326,66128,067(71,279)(13,473)31,66740,518

Comprehensive Income ($ in thousands)

9/30/2024
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
Net income (loss):326,66128,067(71,279)(13,473)31,66740,518
Comprehensive income (loss):326,66128,067(71,279)(13,473)31,66740,518
Other undisclosed comprehensive income (loss), net of tax, attributable to parent222(774)1,563(1,088)148(74)
Comprehensive income (loss), net of tax, attributable to parent:326,88327,293(69,716)(14,561)31,81540,444

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: